Skip to main content
Figure 5 | BMC Complementary and Alternative Medicine

Figure 5

From: Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo

Figure 5

In vitro stimulation (G%) of PBMC of healthy controls, as well as of patients with malanoma or vitiligo, on proliferation by synthetic melanin (5 μg/ml) (A), or by phytohemagglutinin (5 μg/ml) from red beans (B), or by the mixture of melanin and phytohemagglutinin (C), in nutrient medium RPMI 1640 with 10 % autologous plasma. Red squares represent melanoma patients with metastatic disease, while brighter red squares with borders represent melanoma patients without metastases.

Back to article page